Organigram Global (OGI.TO) Stock Price

Organigram Global Price

Frankfurt·CLOSED
1.28
​
Market closed

Revenue has compounded at 108.3% per year over the past 11 years to 259.18 M CAD. Organigram Global's net margin stands at -9.6%, up from -165.1% several years earlier. Analysts set a median price target of 3.57 CAD, implying 178.9% above the current price. Of 9 analysts, 7 rate the stock a buy — an overall Buy consensus.

Organigram Global stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Organigram Global business model & stock analysis

OrganiGram Holdings, Inc. engages in the production and sale of medical marijuana. The company is headquartered in Moncton, New Brunswick. The company went IPO on 2011-11-24. The firm is focused on producing, indoor-grown cannabis for patients and adult recreational consumers in Canada. Organigram is permitted to possess, produce, sell, provide, ship, deliver and transport cannabis, cannabis plants and cannabis oil. Organigram has also developed a portfolio of legal adult use recreational cannabis brands, including Edison, Big Bag O’ Buds, SHRED, Monjour and Trailblazer. The company is also authorized for wholesale shipping of cannabis plant cuttings, dried flower, blends, pre-rolls and cannabis oil to approved retailers and wholesalers for adult-use recreational cannabis under individual provincial and territorial regulations. Laurentian Organic Inc. is a licensed producers of cannabis and cannabis-derived products in Canada.

Frequently asked questions about Organigram Global

Analysts currently set an average price target of 3.44 CAD for the Organigram Global stock (median: 3.57 CAD), implying +168.5 % versus the latest price. The consensus is based on 9 analyst ratings.

9 analysts currently rate the Organigram Global stock: 7 recommend buying, 2 holding and 0 selling. For 2026, analysts expect Organigram Global to generate revenue of 349.77 M CAD and earnings per share of 0.75 CAD.

Converted at the current exchange rate, the Organigram Global share trades at 0.82 EUR (1.28 CAD).

The Organigram Global share (OGI.TO) is listed on 4 stock exchanges, including: NASDAQ (OGI), Frankfurt (0OG.F), München (0OG.MU), Düsseldorf (0OG.DU).

The expected revenue of Organigram Global is 349.77 M CAD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Organigram Global is 102.91 M CAD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Organigram Global is currently 1.70. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Organigram Global stock.

The price-to-sales ratio (P/S) of Organigram Global is currently 0.50. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Organigram Global stock.

The Eulerpool Quality Score for Organigram Global is 6/10.

The ISIN of Organigram Global is CA68617J1003. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Organigram Global is OGI.TO. The ticker symbol is used to trade Organigram Global shares on the stock exchange.

Fair ValueTerminal
1.10 CAD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Pharmaceuticals
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Currency
CAD
Initial public offering
Nov 24, 2011
ISIN
CA68617J1003
Cusip
68620P101
Sedol
BQ963P6
Market capitalization
163.42 M CADMicro Cap
52-Week Range
PEG
0.35
P/E ratio
P/Ee 2026
1.59
P/Ee 2027
20.65
P/Ee 2028
10.97
P/Ee 2029
5.82
P/Ee 2030
4.92
P/S
P/Se
0.50
EV/EBIT
—
P/B Ratio
0.47
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-5.80 %
Last updated Nov 5, 2026, 3:36 AM

Organigram Global Peer Group

Organigram Global Ticker

DÜSSELDORF · 0OG.DUFRANKFURT · 0OG.FMUNICH · 0OG.MUNASDAQ · OGI